BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

 
PEP-1-paraoxonase 1 fusion protein prevents cytokine-induced cell destruction and impaired insulin secretion in rat insulinoma cells
Su Jin Lee1, Hyung Kyung Kang2, Yeon Joo Choi3, Won Sik Eum3, Jinseu Park3, Soo Young Choi3, Hyeok Yil Kwon1,*
1Department of Physiology, College of Medicine, Hallym University,
2Department of Physiology, College of Medicine, Korea University,
3Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University
Abstract
Pancreatic モ cell destruction and dysfunction induced by cytokines is a major cause of type 1 diabetes. Paraoxonase 1 (PON1), an arylesterase with antioxidant activity, has been shown to play an important role in preventing the development of diabetes in transgenic mice. However, no studies have examined the anti-diabetic effect of PON1 delivered to モ cells using protein transduction. In this study, we expressed the cell-permeable PON1 fused with PEP-1 protein transduction domain (PEP-1-PON1) to investigate whether transduced PEP-1-PON1 protects モ cells against cytokine-induced cytotoxicity. PEP-1-PON1 was effectively delivered to INS-1 cells and prevented cytokine-induced cell destruction in a dose-dependent manner. Transduced PEP-1-PON1 significantly reduced the levels of reactive oxygen species (ROS) and nitic oxide (NO), DNA fragmentation, and expression of inflammatory mediators, endoplasmic reticulum (ER) stress proteins, and apoptosis-related proteins in cytokine-treated cells. Moreover, transduced PEP-1-PON1 restored the decrease in basal and glucose-stimulated insulin secretion induced by cytokines. These data indicate that PEP-1-PON1 protects モ cells from cytokine-induced cytotoxicity by alleviating oxidative/nitrosative stress, ER stress, and inflammation. Thus, PEP-1-mediated PON1 transduction might be an effective method to reduce the extent of destruction and dysfunction of pancreatic モ cells in autoimmune diabetes.
Abstract, Accepted Manuscript(in press) [Submitted on August 3, 2018, Accepted on September 10, 2018]
  Copyright © KSBMB. All rights reserved. / Powered by INFOrang.co., Ltd